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ABSTRACT
The Mre11/Rad50/Xrs2 (MRX) complex in
Saccharomyces cerevisiae has well-characterized
functions in DNA double-strand break processing,
checkpoint activation, telomere length maintenance
and meiosis. In this study, we demonstrate an
involvement of the complex in the base excision
repair (BER) pathway. We studied the repair of
methyl-methanesulfonate-induced heat-labile sites
in chromosomal DNA in vivo and the in vitro BER
capacity for the repair of uracil- and 8-oxoG-
containing oligonucleotides in MRX-deficient cells.
Both approaches show a clear BER deficiency for
the xrs2 mutant as compared to wildtype cells. The
in vitro analyses revealed that both subpathways,
long-patch and short-patch BER, are affected and
that all components of the MRX complex are simi-
larly important for the new function in BER. The
investigation of the epistatic relationship of XRS2
to other BER genes suggests a role of the MRX
complex downstream of the AP-lyases Ntg1 and
Ntg2. Analysis of individual steps in BER showed
that base recognition and strand incision are not
affected by the MRX complex. Reduced gap-filling
activity and the missing effect of aphidicoline treat-
ment, an inhibitor for polymerases, on the BER effi-
ciency indicate an involvement of the MRX complex
in providing efficient polymerase activity.
INTRODUCTION
In all organisms, the genome is continuously damaged
by endogenous and exogenous factors, such as reactive
oxygen species (ROS) or alkylating and oxidizing agents.
Frequently, purine and pyrimidine moieties are damaged
yielding base lesions that can lead to mutations (1,2).
8-oxoguanine (8-oxo-G) is the most frequent base
damage induced by hydrogen peroxide (H2O2) (3,4),
whereas alkylating agents such as methyl methan-
esulfonate (MMS) modify bases by adding methyl
groups to nucleophilic sites. The predominant forms of
MMS-induced DNA damage are the N-methylation
adducts 7-methylguanine and 3-methyladenine (5).
Spontaneous depurination of methylated purines leads
to the formation of abasic (AP) sites, which are
heat-labile, due to breakage of the phosphodiester bond
at clustered damage. Presence of unrepaired AP sites
result in cytotoxicity and mutagenicity, as well as blocks
in DNA replication and transcription (6).
Repair of damaged bases and AP sites is normally
carried out by the base excision repair (BER) system.
In patients with defects in BER the failure to repair base
damage can lead to malignancies and is associated with
age-related degenerative diseases (7). BER is initiated by
speciﬁc DNA N-glycosylases that recognize and excise the
damaged bases to produce AP sites (8). In the major BER
subpathway in Saccharomyces cerevisiae AP sites are then
incised by the AP-endonucleases Apn1 and Apn2 creating
a5 0-deoxyribophosphate (50-dRP) end at the site of
damage (9,10). The removal of the blocked 50-end is
catalyzed by Rad27. This protein is a speciﬁc 50-ﬂap
endonuclease extending the AP sites to gaps of up to
5nt (11,12). New DNA synthesis and subsequent
ligation by Cdc9 complete BER (13). In an additional
BER subpathway the damaged bases are processed by a
DNA N-glycosylase/AP-lyase. In S. cerevisiae three
enzymes with combined N-glycosylase-/AP-lyase activities
are known that catalyze the excision of oxidized bases,
namely Ogg1, Ntg1 and Ntg2 (14). 7-methylformamide
pyrimidine, produced by MMS treatment, is excised eﬃ-
ciently by Ntg1 and Ntg2 (15). These enzymes produce
30-a,b-unsaturated aldehydic (30-dRP) ends, which pose a
problem for DNA integrity because they cannot be
extended by polymerases. Genetic studies suggest that
the AP-endonucleases Apn1 and Apn2 contribute to the
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(13). Afterwards, the gap is ﬁlled by polymerase activity
and the original state is reconstituted by the ligase Cdc9
(13). In the case of the repair by AP-lyases, the repair
patch length is not entirely clear (13). However, since elim-
ination of the blocked 30-end creates only a 1-nt gap, it is
designated as the short-patch repair pathway (13,16). The
nucleotide excision repair pathway components Rad1 and
Rad10 provide a backup-pathway for 30-dRP removal
(13). Following the action of an AP-endonuclease, more
than 1nt is incorporated; therefore, this subpathway is
called the long-patch BER (13). The polymerases that
are involved in the BER process in yeast are not known.
Wang et al. (17) could show that DNA synthesis during
repair is carried out mainly by polymerase e, but both,
polymerase a and d show modulating inﬂuences. In
another report, polymerase d was found to be the main
enzyme for DNA synthesis after base damage by
methylating agents (18).
In this article, we address the question of whether Xrs2
also has a direct role in the complex system of BER. Xrs2
is the yeast homolog to human Nbs1. Together with
Mre11 and Rad50, it forms a trimeric complex (MRX)
that is important for damage recognition and processing
after DNA double-strand break (DSB) induction (19–22).
Moreover, the complex plays a role in non-homologous
end-joining (NHEJ) and homologous recombination
(23,24). Besides its function in DSB repair, the MRX
complex also aﬀects many other cellular processes,
including cell cycle checkpoint activation, telomere
length maintenance and meiosis (25). Strains with muta-
tions in RAD52 group genes, including XRS2, are shown
to be sensitive to MMS and H2O2 treatment (26–29).
Furthermore, it was shown that rad52 and xrs2 deletion
strains exhibit an increased mutation frequency compared
to wildtype cells (15,30). Nevertheless, these genes
were never mentioned to be directly linked to the BER
pathway. It was assumed that unrepaired base damage
or BER intermediates can lead to stalled replication
forks which can be converted into DSBs. In addition, clus-
tered DNA base damage and AP sites can induce DSB
(28,31,32). Therefore, it was supposed that
recombination-deﬁcient cells are sensitive to
base-damaging agents due to their role in homologous
recombination as tolerance pathway for unrepaired base
damage (13,33,34).
In this study, we demonstrated a direct role of the yeast
MRX complex in the BER process, which contributes to
resistance against base-damaging agents and to the avoid-
ance of mutations. We showed that the repair capacity of
MMS-induced heat-labile sites in stationary haploid cells
is reduced in the xrs2 mutant compared to wildtype, sug-
gesting a BER defect. Consistently, decreased capacities in
long-patch and short-patch BER were observed in cell
extracts obtained from MRX deletion mutants using an
in vitro assay. Subsequent analyses suggest the assignment
of XRS2 into the NTG1/NTG2-mediated BER sub-
pathway as well as a function in facilitating polymerase
activity required in BER. Thus, our results show for the
ﬁrst time a direct role for the MRX complex in BER.
MATERIALS AND METHODS
Yeast strains and media
The haploid S. cerevisiae strains used in this study are
listed in Table 1. Strains are isogenic derivates of
MKP-0, originally obtained from B.A. Kunz (Geelong,
Australia). Deletion strains were constructed by gene
replacement of the open reading frame and in vivo recom-
bination (35) using polymerase chain reaction (PCR)
products of the cassettes KANMX6 and HIS3MX6
(36) or the selectable markers LEU2, TRP1 and URA3.
All mutations were conﬁrmed by PCR analysis.
Construction and validation of mutants with truncated
XRS2 alleles are described previously (24). Strains used
to measure mutation frequencies are derivates of
BY4741 (37).
Standard medium yeast extract peptone dextrose
(YEPD), containing 2% dextrose, 1% yeast extract and
2% peptone, was used as complete growth medium for
yeast. Synthetic complete (SC) medium (2% dextrose;
0.6% yeast nitrogen base and the appropriate nutrients
added) was used for yeast transformations performed by
the lithium acetate method (38). SC medium lacking one
nutrient allowed selection for the corresponding wildtype
gene. For solid media, 2% agar was added. Canavanine
plates were prepared by dissolving 60mg canavanine
(Sigma) in 1l SC medium lacking arginine. For MMS
plates, the agent was dissolved in concentrations ranging
from 0.0025 to 0.02% in YEPD agar prior to pouring.
All chemicals for media were purchased from Difco.
Analysis of mutation frequency
To measure mutation frequencies we used the strain
BY4741 that carries a wildtype CAN1 gene. Forward
mutations in this gene lead to resistance to the arginine
analog canavanine. For chemical-induced mutagenesis,
overnight cultures were used to inoculate fresh YEPD
medium with 2.5   10
6 cells/ml and incubated until they
reached a cell titer of about 1   10
7cells/ml. For MMS
treatment, cells were incubated for 0, 10, 20 and 30min
with 0.1% MMS (Sigma) at 30 C. Afterwards, the cells
were washed twice with and resuspended in potassium
phosphate buﬀer (25mM KPO4, pH 7.0). For H2O2 treat-
ment, the cells were resuspended in M9 buﬀer (39) con-
taining 0, 1, 3 and 5mM H2O2 (Merck). Following
incubation at 30 C for 20min, the reaction was stopped
by adding 500U/ml catalase (Sigma). To score for cell
survival, the cells were plated onto YEPD and, to screen
for Can
R (canavanine resistant) mutants, spread onto
selective canavanine plates. The mutation frequencies are
displayed as Can
R mutants per 10
7 surviving cells.
Exposure to DNA-damaging agents
The sensitivity of yeast strains to MMS and H2O2 was
measured in the exponential growth phase. Overnight
cultures were diluted in fresh YEPD medium to a
density of 3   10
6 cells/ml and allowed to grow at 30 C
with agitation to about 1   10
7cells/ml. Cells were then
treated with 0.2% MMS for 0, 15, 30 and 45min at 30 C,
pelleted and washed once with YEPD. For the survival
1854 Nucleic Acids Research, 2010,Vol.38, No. 6after H2O2 treatment, aliquots of 1ml were incubated for
20min with H2O2 concentrations ranging from 0 to
60mM as described by Melo et al. (39). The addition of
500U/ml catalase stopped the reaction. Appropriate dilu-
tions were spread on YPED agar. After plating, cells were
incubated for 3–5 days at 30 C. Survival was calculated by
the ratio of the number of colonies after treatment versus
the number of colonies without treatment.
For a crude analysis of the MMS sensitivity, cells in
exponential growth phase were diluted serially in
potassium phosphate buﬀer (25mM KPO4, pH 7.0), and
aliquots of 5ml were spotted on YEPD agar supplemented
with 0.0025–0.02% MMS.
Repair of heat-labile sites after MMS treatment
The eﬃciency to repair heat-labile sites after MMS treat-
ment in vivo was measured in haploid yeast cells under
non-growth conditions. To obtain highly stationary
yeast cells with a maximum of 3% budding cells, a
modiﬁed cultivation protocol of Pohlit and Heyder (40)
was used. Cells were collected, diluted in potassium phos-
phate buﬀer (25mM KPO4, pH 7.0) to a density of
7.5 10
8 cells/ml and treated for indicated time points
with 0.1% MMS, followed by washing twice with
potassium phosphate buﬀer. Afterwards, the samples
were diluted in liquid holding recovery (LHR) buﬀer
(100mM glucose, 67mM KPO4, pH5.0) (41–43) to a
ﬁnal density of 7.5 10
6 cells/ml and incubated at 30 C.
The cells were embedded into agarose plugs before and
after LHR incubation and genomic DNA was prepared
according to Friedl et al. (43). During incubation at 55 C
for proteinase K digestion MMS-induced clustered
heat-labile sites are converted into DSB (31). Incubation
at 32 C for the digestion step was used to check the basal
level of chromosomal degradation. Chromosomal
DNA was separated by pulsed-ﬁeld gel electrophoresis
(PFGE). The evaluation of residual damage was carried
out with the software Geltool, that calculates proﬁle values
(pv’s) representing the extent of chromosomal degrada-
tion. Details were described previously (24).
Preparation of cell-free protein extracts
Fifty milliliters of YEPD was inoculated with a single
colony and the culture was grown to stationary growth
phase at 30 C. The pre-culture was diluted 10-fold with
YEPD medium and incubated under vigorous shaking
at 30 C to early logarithmic growth phase (5   10
6
 1   10
7cells/ml). The cells were kept on ice for
20min, centrifuged (4000r.p.m., 4 C, 20min) and
washed twice with potassium phosphate buﬀer (25mM
KPO4, pH 8.0). Afterwards, the cell pellet was
resuspended in 5ml ice-cold extraction buﬀer (100mM
Tris–HCl, pH 8.0; 10mM b-mercaptoethanol) and 1ml
protease inhibition mix (Sigma) was added per 20g of
cell pellet. Cells were crushed by using a pre-chilled
French Press Cell (Aminco) applying an internal
pressure of 20000psi. The crude extract was adjusted to
pH 8.0 by adding 0.1M NaOH and the cell debris was
removed by centrifugation at 20000r.p.m. in a SS34 rotor
for 40min at 4 C. The supernatant was carefully removed
without disturbing the pellet. Protein was precipitated by
stepwise addition of ammonium sulfate to a concentration
of 0.35g/ml for at least 20min on ice, collected by
centrifugation (20000r.p.m., 30min, 4 C), dissolved in
3ml dialysis buﬀer (10mM Tris–HCl, pH 7.5; 10mM
b-mercaptoethanol) and then dialyzed overnight at 4 C
against the same buﬀer. The extract was further
centrifuged for 10min to remove insoluble particles. The
crude extract was either used directly or stored for up to 6
months at –80 C before use. Protein concentrations were
determined according to Bradford using BSA as standard.
Preparation of substrates for in vitro assays
For in vitro BER assays, single-strand (ss)DNA oligonu-
cleotides (35-mer) containing a uracil residue (BER1=
50-GCC CTG CAG GTC GAU TCT AGA GGA TCC
CCG GGT AC-30) or an 8-oxoG (BER3=50-GCC CTG
CAG GTC GAG
8-oxo TCT AGA GGA TCC CCG GGT
AC-30) at position 15 were annealed to their complemen-
tary synthetic strands (BER2=50-GTA CCC GGG GAT
CCT CTA GAG TCG ACC TGC AGG GC-30 and
BER4=50-GTA CCC GGG GAT CCT CTA GAC
Table 1. Saccharomyces cerevisiae strains used in this study
Strain Genotype Reference
MKP-0 MAT, can1-100, ade2-1, lys2-1, ura3-52, leu2-3-112, his3-D200, trp1-D901, RAD BA. Kunz
MKP-0 Dxrs2 Derivative of MKP-0 with XRS2::KANMX6 (24)
MKP-0 xrs2-228M Derivative of MKP-0 Dxrs2 with xrs2-228M (24)
MKP-0 xrs2-630 Derivative of MKP-0 Dxrs2 with xrs2-630 (24)
MKP-0 Dapn1 Derivative of MKP-0 with APN1::Leu2 This study
MKP-0 Dapn1Dxrs2 Derivative of MKP-0 with APN1::Leu2, XRS2::KANMX6 This study
MKP-0 Dntg1Dntg2 Derivative of MKP-0 with NTG1::URA3, NTG2::TRP1 This study
MKP-0 Dntg1Dntg2Dxrs2 Derivative of MKP-0 with NTG1::URA3, NTG2::TRP1, XRS2::HIS3MX6 This study
MKP-0 Dapn1Dntg1Dntg2 Derivative of MKP-0 with APN1::Leu2, NTG1::URA3, NTG2::TRP1 This study
MKP-0 Dapn1Dntg1Dntg2Dxrs2 Derivative of MKP-0 with APN1::Leu2, NTG1::URA3, NTG2::TRP1, XRS2::HIS3MX This study
MKP-0 Dmre11 Derivative of MKP-0 with MRE11::HIS3MX6 (24)
MKP-0 Drad50 Derivative of MKP-0 with RAD50::LEU2 (24)
BY4741 MATa; his3D1; leu2D0; met15D0; ura3D0 Euroscarf
BY4741 Dxrs2 MATa; his3D1; leu2D0; met15D0; ura3D0 with xrs2::KANMX6 Euroscarf
Nucleic Acids Research,2010, Vol.38, No. 6 1855TCG ACC TGC AGG GC-30). Annealing was performed
by mixing equimolar amounts of both oligonucleotides
and incubating them for 10min at 95 C followed by
slow cooling down to room temperature. For the in vitro
incision assay BER1 was labeled prior to annealing
using T4 polynucleotide kinase (MBI-Fermentas) and
[g-
32P]ATP according to the manufacturer’s instructions.
Afterwards, the substrate was puriﬁed using G-25
Sephadex minicolumns (Roche) to remove unincorporated
[g-
32P]ATP. To measure the gap-ﬁlling activity of cell
extracts, a 14-nt ssDNA oligonucleotide (BER5=
50-GCC CTG CAG GTC GA-30) was labeled, while the
50-end of a 17–nt-long oligonucleotide (BER6=50-AGA
GGA TCC CCG GGT AC-30) was non-radioactively
phosphorylated. The annealing of BER5 and BER6 to
BER2 generated a repair substrate lacking 4nt in one
strand.
In vitro repair assays
To determine the BER capacity of cell-free extracts, an
in vitro BER assay was performed according to Harrigan
et al. (44). Brieﬂy, 20mg protein were dissolved in BER
reaction buﬀer (50mM HEPES, pH 7.5; 0.5mM EDTA;
2mM dithiothreitol; 20mM KCl; 4mM ATP; 5mM
phosphocreatine; 0.5mM NAD
+; 0.1mM ddTTP;
100mg/ml freshly prepared phosphocreatine kinase) and
preincubated with 250nM oligonucleotide substrate
(BER1+BER2 or BER3+BER4) for 5min at room
temperature. Addition of 2.2mM[ a-
32P]dCTP and
10mM MgCl2 initiated the repair reaction and the
samples were incubated at 37 C for the indicated time
points. The reactions were stopped by adding 5mM
EDTA and heating for 5min to 72 C. Puriﬁcation
with G-25 Sephadex minicolumns (Roche) according
to the manufacturer’s instructions was done to remove
unincorporated [a-
32P]dCTP. Afterwards, repair
substrates were mixed with an equal volume of DNA
loading dye (95% formamide; 20mM EDTA; 0.02%
bromphenol blue; 0.02% xylene cyanol) and incubated
for 2min at 72 C. For inhibition of polymerases protein
extracts were preincubated for 30min at 30 C with 2mg/ml
aphidicoline.
The in vitro incision assay was carried out on the basis
of Wang et al. (45). Two-hundred and ﬁfty nanomoles
of oligonucleotide substrate ([g-
32P]BER1+BER2) were
incubated in 10ml incision reaction buﬀer (50mM
HEPES, pH 7.7; 7.5mM MgCl2; 0.5mM EDTA; 1mM
dithiothreitol; 20mM phosphocreatine; 2% glycerol;
100mg/ml bovine serum albumin) with 1mg cell free
protein extract for the indicated time points at 23 C.
The reactions were terminated by adding 20ml stop
solution (250mM HEPES, pH 7.5; 1% sodium dodecyl
sulfate (SDS); 500mg/ml proteinase K) and heating for
20min to 60 C. Repair products were ethanol-precipitated
and solubilized in DNA loading dye as mentioned above.
For the gap-ﬁlling assay, 40mg cell extract were mixed
with 10nM oligonucleotide substrate (BER2+
[g-
32P]BER5+BER6) and reaction buﬀer (50mM
Tris, pH 7.4; 50mM KCl; 1mM dithiothreitol; 5mM
MgCl2; 5% glycerol). 2.5mM dCTP and 2.5mM dTTP
were added. Reactions were stopped by adding 5mM
EDTA, mixed with 10ml loading dye and heated for
5min to 72 C.
All repair products were separated by polyacrylamide
gel electrophoresis (24% acrylamide for the BER assay
and the gap-ﬁlling assay and 18% acrylamide for the inci-
sion assay; 8M urea; 89mM Tris–HCl, pH 8.8; 89mM
boric acid; 2mM EDTA), detected by autoradiography
and quantiﬁed by digital imaging (TotalLab, Amersham).
RESULTS
Deletion of XRS2 leads to high mutation frequency
and MMS sensitivity
Mutations in RAD52 group genes lead to increased
sensitivities to alkylating and oxidizing agents (26–28)
and a genome-wide screen showed increased mutation
frequencies after MMS treatment (15,30). We veriﬁed
these ﬁndings in our experimental systems for the
deletion of XRS2 and RAD52. Both, the xrs2 mutant
and the recombination-deﬁcient mutant rad52, conferred
a high sensitivity to MMS and H2O2, whereas the xrs2
mutant shows an even higher sensitivity to H2O2 treat-
ment as compared to the rad52 mutant (Figure 1A and
B). Mutation frequencies were determined with a forward
mutation system leading to canavanine resistance
(Figure 1C and D). In wildtype cells, the spontaneous
mutation frequency averaged 20 Can
R mutants per 10
7
cells, while deletion of XRS2 increased the frequency
5–6-fold to 100–120 mutants per 10
7 cells. Furthermore,
xrs2 mutants exhibited an elevated mutation frequency
after MMS treatment. Following incubation for 30min
in 0.1% MMS the number of Can
R mutants in the xrs2
strain was raised to 550 per 10
7 survivors, while in
wildtype cells the number increased only to 200 Can
R
mutants. Mutation frequencies were also increased in the
xrs2 mutant after H2O2 treatment. Incubation in 5mM
H2O2 yielded 130 mutants per 10
7 survivors in wildtype
cells and 260 mutants per 10
7 survivors in the xrs2 deletion
mutant. These results emphasized the importance of XRS2
and RAD52 to preserve genomic stability after treatment
with base damaging agents.
Xrs2 plays a role in the repair of heat-labile sites after
MMS treatment
For many years, MMS was used as radiomimetic agent, to
introduce DSB into DNA (46). New results, however,
showed that MMS-induced DSB, which can be detected
by PFGE, are due to elevated temperatures in DNA
preparation where MMS-induced heat-labile sites are con-
verted to DSB (31,47). We used this method to investigate
the repair of MMS-induced heat-labile sites in stationary
cells from wildtype, xrs2 and rad52 deletion strains. We
determined the residual DNA damage 23h after MMS
treatment with 0.1% MMS for 0, 10, 20, 40 and 60min.
DNA damage repair was facilitated by incubating the
cells under non-growth conditions (LHR), which allows
DNA repair while proliferation is suppressed (41–43).
Residual heat-labile sites were converted into DSB
during proteinase K incubation at 55 C for DNA
1856 Nucleic Acids Research, 2010,Vol.38, No. 6agarose plug preparation. As a control, DNA plugs were
also prepared at 32 C. The resulting gel showed distinct
bands of chromosomal DNA and little background in
untreated and MMS-treated samples prepared at 32 C
from both, wildtype and xrs2 strains (Figure 2A). This
result indicated that there were equally low levels of
DSB in wildtype and in the xrs2 mutant, and no direct
induction of DSB by MMS was detectable in both strains.
The results for DNA preparation at 55 C 0h and 23h
after irradiation are shown in Figure 2B. Immediately
after MMS treatment, the DNA fragmentation increased
dependent on the length of MMS treatment. Twenty-three
hours after incubation under LHR conditions, DNA
repair was visible as the reappearance of chromosomal
bands. To quantify the extent of chromosomal degrada-
tion we used the software program Geltool (24) and the
residual damage was plotted against the time of MMS
treatment (Figure 2C). Dependent on treatment time,
the amount of residual damage increased moderately in
wildtype (slope of regression line 0.0268), while there
was a more pronounced accumulation of residual
damage in the xrs2 mutant (slope of regression line
0.0527). In line with a recent publication (31), we found
that the HR-deﬁcient rad52 mutant shows a repair activity
comparable to wildtype cells (slope of regression line
0.0304). Relative quantiﬁcation of slopes of regression
lines showed a 2-fold enhanced increase in the xrs2
mutant (Figure 2D). Furthermore, the xrs2 mutant
exhibited a marginally increased amount of heat-labile
sites in untreated cells. Therefore, the reduced ability of
the xrs2 mutant to repair MMS-induced heat-labile sites
was not due to reduced recombinational repair, a backup
pathway for the repair of DNA base damage.
Xrs2 is directly involved in the BER pathway
The results from the analysis of MMS-induced heat-labile
sites suggested an involvement of XRS2 in the repair of
DNA base damage. To further elucidate this assumption
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Figure 1. Sensitivity to base-damaging agents and mutation frequencies. (A, B) Sensitivity of the xrs2 deletion mutant to MMS and H2O2 compared
to MKP-0 wildtype and the rad52 deletion mutant. Survival was plotted as the ratio of colonies obtained after treatment versus colonies obtained
without treatment. (C, D) Induced mutation frequencies of BY4741 wildtype and its isogenic xrs2 deletion mutant after MMS and H2O2 treatment
shown as canavanine-resistant (Can
R) mutants per 10
7 survivors. Results are an average of three independent experiments±SD.
Nucleic Acids Research,2010, Vol.38, No. 6 1857we employed an in vitro BER assay according to Harrigan
et al. (44) (Figure 3A). We analyzed the repair of 35-bp
double-stranded oligonucleotides containing a uracil or
an 8-oxoG at position 15. These substrates were incubated
with the same amounts of protein extracted from wildtype
cells and xrs2 mutant cells in logarithmic growth phase.
During the repair process damaged bases (uracil and
8-oxoG) are removed from the substrate and a
[a-
32P]dCTP or a [a-
32P]dGTP was incorporated
opposite G or C, respectively. Before ligation, this inter-
mediate has a size of 15nt; after ligation the original size
of 35nt was restored. To distinguish between short-patch
repair, where only 1nt is substituted, and long-patch
repair, where a number of nucleotides were replaced,
ddTTP is added to the reaction mixture to abort elonga-
tion. This allowed detecting long-patch repair products
with a size of 16nt. Using an error-free oligonucleotide,
we observed no repair products (data not shown). Figure
3B shows a representative experiment for the repair of a
uracil-containing oligonucleotide by cell extracts from
wildtype cells and from the xrs2 mutant. It has to be
noted that exposure times were diﬀerent for monitoring
long-patch and short-patch repair. In line with current
publications usage of equal exposure times revealed
clearly higher amounts of long-patch products (13,48),
but quantiﬁcation was hardly possible (data not shown).
The amount of all three detectable repair products (inter-
mediate, long patch and short patch) were reduced in
extracts obtained from the xrs2 mutant. The formation
of repair products was similarly reduced for an 8-oxoG
containing oligonucleotide in the BER assay (Figure 3C).
The quantitative examination of at least three independent
Figure 2. Analysis of the repair of heat-labile sites. (A) Induction of chromosomal degradation in wildtype and the xrs2 mutant visualized by
pulsed-ﬁeld gel electrophoresis. Cells were treated for 0, 15 and 30min with 0.1% MMS. During preparation of chromosomal DNA, the incubation
with proteinase K was carried out at 32 C (heat-labile sites remain stable) as well as 55 C (heat-labile sites are converted into DSB). (B) Analysis of
chromosomal degradation (proteinase K incubation at 55 C) immediately after treatment for 0, 20 and 40min with 0.1% MMS as well as after 23h
incubation of the cells under LHR conditions. (C) Residual DNA fragmentation plotted against the time of MMS treatment. The degree of residual
chromosomal degradation was quantiﬁed using the software program Geltool and is shown as proﬁle value (pv). Linear equations are calculated from
regression lines (dashed lines). One representative experiment is shown. (D) Slope of regression lines obtained from residual chromosomal degra-
dations from the xrs2 and rad52 mutant relative to wildtype. Mean values from three independent experiments for the xrs2 mutant and for wildtype
are shown. The rad52 mutant was analyzed once.
1858 Nucleic Acids Research, 2010,Vol.38, No. 6extracts showed that the amount of short-patch and
long-patch products synthesized by xrs2 extracts within
20min was reduced to 0.64-fold the amount produced
by wildtype extracts. The intermediate constituted
0.77-fold of the amount synthesized by wildtype extracts
(Figure 3D). In contrast, extracts from the rad52 mutant
remained BER proﬁcient (Figure 3E). For the ﬁrst time,
we demonstrated reduced BER capacity in cell free
extracts from the xrs2 mutant for the repair of both,
uracil- and 8-oxoG-containing oligonucleotides.
The new role of Xrs2 in BER is a function of the whole
MRX complex
Xrs2 forms a trimeric complex with Mre11 and Rad50
(49). To analyze whether the newly detected role of Xrs2
in BER is a function of Xrs2 alone, or of the whole MRX
complex, we analyzed MMS sensitivity and in vitro
BER capacity in mre11 and rad50 deletion mutants.
Since it was previously shown that several N- and
C-terminal truncated versions of XRS2 exhibit MMS sen-
sitivity (50), we also analyzed two recently constructed
xrs2 mutants (24) either lacking the FHA- and
BRCT-domains at the N-terminus (xrs2-228M) or the
Tel1- and Mre11-binding domains at the C-terminus
(xrs2-630) for their BER capacity. Figure 4 shows that
all mutants except the xrs2-228M mutant behaved like
the xrs2 mutant. Reduced BER capacities and increased
sensitivity against MMS were equally evident for the
mre11, rad50 and xrs2-630 mutant, and comparable to
that seen in the xrs2 deletion mutant. Thus, we concluded
that the complete MRX complex is involved in the BER
pathway and especially the Mre11-binding domain of
Xrs2 is important, while the FHA- and the BRCT-
domains have no function in BER.
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Figure 3. In vitro analysis of short-patch and long-patch BER with whole-cell extracts from wildtype cells and from the xrs2 mutant. (A) Principle of
the in vitro assay (X=uracil or 8-oxoG). Labeled repair products are generated by BER activity of whole cell extracts. (B, C) Repair capacities for
the repair of the uracil-containing oligonucleotide (B) and the 8-oxoG-containing oligonucleotide (C) of cell extracts obtained from wildtype cells and
from the xrs2 mutant. The number below the images indicates the relative intensity of the corresponding band relative to the strongest band in that
line. (D) Relative BER activity of the xrs2 mutant after a 20-min repair time. The diagram shows the average of three independent experiments using
the uracil-containing oligonucleotide; the results for the 8-oxoG-containing substrate were obtained from one experiment. (E) Analysis of the BER
capacity in cell extracts from the rad52 mutant in comparison to cell extracts from wildtype cells and the xrs2 mutant using the uracil-containing
substrate. One representative experiment out of three is shown. nd., not determined.
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in BER
To assign the MRX complex to the AP-endonuclease or
the AP-lyase subpathway we analyzed the epistatic rela-
tionship of XRS2 and other BER genes concerning
survival and in vitro BER capacity. We deleted XRS2 in
an apn1 mutant, where the major BER pathway in yeast
via the AP-endonuclease Apn1 is blocked. The AP-lyase
pathway remains unaﬀected because in this mutant Apn2
can act as an eﬃcient 30-phosphodiesterase and compen-
sate for the APN1 deletion in this function (13).
Furthermore, we deleted XRS2 in the AP-lyase deﬁcient
mutant ntg1ntg2. Finally, we compared the quadruple
mutant xrs2apn1ntg1ntg2 to the triple mutant
apn1ntg1ntg2. The apn1 mutant exhibited a moderate
MMS sensitivity (Figure 5A and B), while survival was
hardly inﬂuenced by the deletion of NTG1 and NTG2
(Figure 5B). An eﬀect of the ntg1ntg2 deletion appeared
after additional deletion of apn1, when both the
AP-endonuclease and the AP-lyase subpathways were
impaired. Additional deletion of XRS2 in the apn1 back-
ground enhanced the sensitivity. In contrast, deletion of
NTG1 and NTG2 suppressed the high MMS sensitivity of
the xrs2 single mutant, resulting in the phenotype of the
ntg1ntg2 double mutant. Similarly, the xrs2 phenotype
was suppressed in the quadruple mutant xrs2apn1ntg1ntg2
(Figure 5B).
Similar eﬀects were observed in the in vitro BER assays
(Figure 5C and D). The apn1 mutant produced less inter-
mediate and long-patch products when compared to
wildtype, while the short-patch capacity was not
inﬂuenced. The apn1xrs2 double mutant showed an
additive eﬀect on long-patch BER activity, while the
short-patch BER activity of the xrs2 phenotype was
observed. Compared to wildtype cells the ntg1ntg2
mutant showed no BER defect. Moreover, the additional
deletion of XRS2 hardly inﬂuenced the repair capacity.
For all three repair products the xrs2 phenotype was
almost completely suppressed. We also tried to analyze
the apn1ntg1ntg2 triple mutant and the apn1ntg1ntg2xrs2
quadruple mutant for their BER capacity, but insuﬃcient
repair products were generated (data not shown).
Therefore, it was not possible to draw a conclusion for
the inﬂuence of an additional XRS2 deletion. However,
due to the additive eﬀect of APN1 and XRS2, as well as
the suppressive eﬀect, of the NTG1 and NTG2 deletion on
the xrs2 phenotype, we propose an involvement of the
MRX complex downstream of the AP-lyases.
Functional analysis of the BER mechanism after
deletion of XRS2
To analyze the eﬃciencies of base recognition and DNA
incision at the AP site we carried out an in vitro base
incision assay using the same uracil-containing substrate
as in the BER assay labeled at the 50-end. If the uracil is
recognized and removed and the DNA is incised, a 14-nt
and a 15-nt-long product is generated (Figure 6A). The
speciﬁcity of the reaction was tested with diﬀerent control
approaches. Without cell extract no incision could be
detected. The addition of exogenous recombinant uracil
glycosylase (UDG) from Escherichia coli caused the
removal of uracil, while the phosphate backbone was
B
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Figure 4. MMS sensitivity and BER capacity of MRX-deﬁcient cells and mutants carrying truncated versions of the Xrs2 protein. (A) Analysis of
the MMS sensitivity. Shown are serial dilutions of cells on plates containing MMS as indicated. (B) Repair capacity of cell extracts obtained from the
mre11, the rad50 mutant and from strains expressing truncated versions of XRS2 compared to wildtype and the xrs2 deletion mutant. The numbers
below the images indicate the relative intensity of the corresponding band relative to the strongest band in that line. One of three independent
experiments is shown.
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Figure 6B (left part of image) shows that an extract
from the xrs2 mutant produced the same amount of
incision product compared to an extract from wildtype
cells. However, deletion of APN1 led, as expected, to a
clear defect in the incision assay (Figure 6B, middle part of
image). Therefore, the ﬁrst steps in BER, base recognition
and DNA incision, were not inﬂuenced by Xrs2.
Following removal of the damaged base, the gap has to
be ﬁlled by polymerase activity. To measure strand elon-
gation reactions we carried out a gap-ﬁlling assay where
the substrate mimics an intermediate of the long-patch
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Figure 5. Epistatic relationship of XRS2 to other BER genes. (A, B) Analysis of MMS sensitivity. Shown are serial dilutions of cells on plates
containing MMS as indicated. (C) Repair capacity for the repair of the uracil-containing oligonucleotide of cell extracts obtained from the apn1 and
the apn1xrs2 mutant compared to cell extracts from wildtype cells and from the xrs2 single mutant. (D) Repair capacity for the repair of the
uracil-containing oligonucleotide of cell extracts derived from the ntg1ntg2 double mutants and ntg1ntg2xrs2 triple mutant compared to cell extracts
derived from wildtype cells and from the xrs2 single mutant. In each case, one representative experiment out of three is shown. (E) Proposed model
for the allocation of XRS2 to the AP-lyase-mediated repair pathway. The phenotypes of the apn1 and xrs2 single mutants are combined in the
apn1xrs2 double mutant; otherwise, the eﬀect of xrs2 is suppressed in the ntg1ntg2 mutant. These ﬁndings assign the MRX complex downstream of
the AP-lyases where short-patch and long-patch repair products can be synthesized.
Nucleic Acids Research,2010, Vol.38, No. 6 1861pathway with a gap of 4nt in one strand. Since no ATP
for ligase activity was added the products can only reach a
length of 15–18nt (Figure 6C). Compared to wildtype
the xrs2 mutant showed decreased gap-ﬁlling activity
(Figure 6D). While extracts from wildtype cells were
able to ﬁll in the missing 4nt within 15min, the xrs2
mutant showed no strand elongation within 60min
incubation time. A further indication for reduced
polymerase activity in the xrs2 mutant can be seen in
the in vitro BER assay with cell extracts supplemented
with 2mg/ml aphidicoline for the inhibition of polymerases
(Figure 6E). In the wildtype extract, aphidicoline treat-
ment reduced the amount of both, short-patch and
long-patch product, 0.5-fold compared to mock-treated
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Figure 6. Analysis of individual steps in the BER process after deletion of XRS2.( A) Incision assay using the uracil-containing oligonucleotide.
Generation of an AP site and incision activity can be monitored through the appearance of cut products of the labeled substrate. (B) Incision assay
with whole-cell extracts derived from wildtype cells and form the xrs2 (left part of image) and the apn1 (middle part of image) mutant. Stability of
the phosphodiester bond was demonstrated by using an UDG-treated (Uracil-DNA-Glycosylase) substrate. The successful generation of AP-sites
after UDG-treatment was shown by hydrolyzing the phosphodiester bond under alkaline conditions (right part of image). (C) Four-nucleotide
gap-ﬁlling assay; gap-ﬁlling activity is visible through the extension of the 50-labeled substrate. (D) Gap-ﬁlling activity of cell extracts derived from
the xrs2 mutant compared to cell extracts from wildtype cells. (E) In vitro BER assay of whole-cell extracts from wildtype cells and from the xrs2
mutant preincubated with 2mg/ml aphidicoline for 30min. In each case, one representative experiment out of three is shown.
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aphidicoline treatment had no impact on strand elonga-
tion and polymerization activity was equally low in treated
and untreated xrs2 extracts. This indicates that the main
part of new DNA synthesis in wildtype cells is executed by
an aphidicoline sensitive polymerase, while the residual
amount of repair synthesis in the xrs2 mutant is done by
an aphidicoline insensitive polymerase.
DISCUSSION
In this study, we demonstrated that fully active BER is
dependent on an intact MRX complex activity in
S. cerevisiae. This was evidenced by an impaired repair
of chromosomal heat-labile sites, which are clusters of
base damage, in the xrs2 deletion strain. Furthermore,
whole-cell extracts from strains containing deletions in
MRX component genes displayed reduced repair eﬃ-
ciency in an in vitro BER assay as well as decreased
gap-ﬁlling activity.
Deletion of XRS2 led to an elevated spontaneous
mutation frequency as well as to increased induced
mutation frequency and increased sensitivities after
MMS and H2O2 treatment (15,30). So far, this was
explained by the role of the RAD52 epistasis group
genes facilitating recombinational repair as part of a tol-
erance pathway for stalled replication forks after base
damage (28,31,32). However, we detected diﬀerences in
the repair of MMS-induced chromosomal DNA damage
between the rad52 deletion mutant and the xrs2 mutant.
The rad52 mutant repaired the induced damage within
23h as eﬃciently as wildtype cells, consistent with the
assumption that replication bypass and recombinational
repair were less important in G1 haploid cells. In contrast,
in the xrs2 deletion mutant the residual damage was
increased about 2-fold as compared to wildtype and the
rad52 mutant. As the assay detected damaged bases,
abasic sites and intermediate breaks arising during BER
(31,47), this observation hinted at a role for XRS2 in BER
that is independent of RAD52.
This assumption was further supported by the results of
an in vitro BER assay modiﬁed from Harrigan et al. (44).
Whole-cell extracts from the xrs2 mutant showed only
60% of the repair capacity of wildtype or the rad52
mutant within 20min. Since it was possible to distinguish
between short-patch and long-patch BER with this assay,
we could show that both subpathways were equally
aﬀected by deletion of XRS2. Therefore, the function
of XRS2 in BER should be upstream of the branching
of the two pathways. Alternatively, XRS2 could be
independently required for both subpathways. This BER
defect can be seen in the repair of both, 8-oxoG and uracil,
indicating a function for XRS2, independent of the native
of the damaged base. Further analysis of mre11 and rad50
mutants demonstrated that the new function of Xrs2 is a
function of the complete MRX complex. The in vitro BER
capacity in all three mutants was decreased to a similar
extend. In addition, we analyzed BER activity in mutants
lacking the Mre11-binding domain or the N-terminus,
including the FHA and BRCT domain of Xrs2, which
were shown to be important for NHEJ (51). These exper-
iments revealed that the truncation of the Mre11-binding
domain was suﬃcient for the inactivation of the Xrs2
protein in BER.
To further elucidate the involvement of Xrs2 in BER,
we investigated the epistatic relationship of XRS2 to both
BER subpathways. We combined the deletion of XRS2
with deletions blocking either the AP-endonuclease-
dependent long-patch repair pathway, which is most
important in S. cerevisiae or the mechanistically less
deﬁned AP-lyase-mediated subpathway (13). In agreement
with the current model of BER, the APN1 deletion dis-
played a clear defect in long-patch BER. The apn1xrs2
double mutant showed an additive eﬀect in the long-patch
repair and the xrs2 defect in the short-patch repair. An
additive eﬀect was also observed for MMS sensitivity.
Therefore, we concluded that XRS2 and APN1 act on
diﬀerent pathways concerning DNA base damage
removal. Deletion of NTG1 and NTG2 had no eﬀect on
BER and survival after MMS. This was consistent with
the minor importance of the AP-lyase-mediated BER
pathway (7,13). Otherwise, the function of Ntg1 and
Ntg2 could be replaced by other lyases, like Ogg1.
Interestingly, the eﬀects of the XRS2 deletion were
almost completely suppressed by the additional deletion
of NTG1 and NTG2. In conclusion, our data suggested
that the MRX complex acts downstream of Ntg1 and
Ntg2 in the AP-lyase-mediated repair pathway and that
intermediates resulting from incomplete processing in this
pathway due to the XRS2 deletion were more severe than
blocking the whole subpathway. In addition to the current
model, our data suggest that in this pathway short-patch
and long-patch repair products were synthesized instead
of short-patch products only.
The lack of inﬂuence of XRS2 on the incision assay
demonstrated that base recognition and the generation
of single-strand breaks were independent of XRS2 and
put the role of the MRX complex downstream of
damage recognition and strand incision, which ﬁtted
with the fact that both, the repair of a uracil-containing
and an 8-oxoG-containing oligonucleotide, were aﬀected
in the xrs2 mutant. Most likely, the role of the MRX
complex is the enabling of an eﬃcient polymerase
activity. This assumption was substantiated by two
ﬁndings: (i) the gap-ﬁlling assay directly showed that
protein extracts from the xrs2 mutant display a decreased
polymerization activity and (ii) the inhibition of
polymerases by aphidicoline demonstrated that a major
part of DNA synthesis in BER was executed by an
aphidicoline-sensitive polymerase(s) in wildtype, whereas
aphidicoline treatment had no impact in xrs2 extracts,
indicating that this (these) polymerase(s) was already
inactive as a consequence of the XRS2 deletion.
In mammalian cells, the WRN protein, a member of the
RecQ helicase family, was demonstrated to activate BER
by interacting with key players of this pathway. WRN
cooperated especially with Polb, the most important
polymerase for BER in mammalian cells that is needed
for the insertion of the ﬁrst nucleotide in the gap-ﬁlling
step (44,52). WRN also interacts with Nbs1 (53), the
mammalian homolog of Xrs2, which was recently shown
Nucleic Acids Research,2010, Vol.38, No. 6 1863to be involved in BER (54). The authors suggested a role
of Nbs1 in the recruitment step of Polb. In yeast cells it
was already shown that the RecQ helicase Sgs1 forms
a complex with Mre11 following MMS treatment (55).
We speculate that, like in mammalian cells, a large
complex, composed of MRX and further BER factors, is
needed to activate BER by managing the recruitment of
polymerases for the repair process. Our results demon-
strate that the MRX complex is a requisite for the eﬃcient
repair of DNA base damage, in addition to its
better-known functions in DNA DSB repair. Further
studies will be needed to identify the exact role and the
interaction partners of the MRX complex in the BER
pathway.
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